Diagnos Inc V.ADK

Alternate Symbol(s): DGNOF

Healthcare Medical Devices

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.

TSXV:ADK - Post by User

Diagnos Inc

Bullboard Posts

Comment by theorlandoon Dec 23, 2009 12:49pm

185 Views

Post# 16614476

RE: Easy money here

DIAGNOS Has Commenced U.S. Food and Drug Administration (FDA)Registration Process for Its CARA Application

10:00 AM ET, December 21, 2009

BROSSARD, QUEBEC, Dec 21, 2009 (MARKETWIRE via COMTEX) --December 21st, 2009 - DIAGNOS inc. ("DIAGNOS" or "theCorporation")(TSX VENTURE: ADK), a leader in the use of artificialintelligence and advanced knowledge extraction techniques, announcedtoday that it has begun the U.S. FDA registration process for itsCARA (Computer Assisted Retinal Analysis) application with theintention of commercializing services derived from CARA in the UnitedStates in the coming months.

When they get this the stock will move.

Bullboard Posts

Fobi AI responds to cease trade order, filing delay “disappointing”